Search results

98 results

Sorted by Date . Sort by Relevance

Guidance Remove Guidance filter
In development Remove In development filter
Awaiting development Remove Awaiting development filter
In consultation Remove In consultation filter
Proposed Remove Proposed filter
NICE guidelines Remove NICE guidelines filter
Highly specialised technologies guidance Remove Highly specialised technologies guidance filter
Diagnostics guidance Remove Diagnostics guidance filter
Public health guidelines Remove Public health guidelines filter
Antimicrobial prescribing guidelines Remove Antimicrobial prescribing guidelines filter
Quality standards Remove Quality standards filter

Vitamin B12 deficiency, including pernicious anaemia: diagnosis and management

In development [GID-NG10176] Expected publication date: 01 November 2023

Type

NICE guideline

Status

In development
Afamelanotide for treating erythropoietic protoporphyria [ID927]

In development [GID-HST10009] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Palovarotene for treating flare ups of heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID2721]

In development [GID-HST10033] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Eteplirsen for treating Duchenne muscular dystrophy [ID1003]

In development [GID-HST10007] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Skin abscess: antimicrobial prescribing

In development [GID-NG10163] Expected publication date: TBC

Type

Antimicrobial prescribing guideline

Status

In development
Conjunctivitis: antimicrobial prescribing

In development [GID-NG10166] Expected publication date: TBC

Type

Antimicrobial prescribing guideline

Status

In development
Blepharitis: antimicrobial prescribing

In development [GID-NG10168] Expected publication date: TBC

Type

Antimicrobial prescribing guideline

Status

In development
Stye: antimicrobial prescribing

In development [GID-NG10167] Expected publication date: TBC

Type

Antimicrobial prescribing guideline

Status

In development
Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]

In development [GID-HST10050] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Osteoporosis: assessing the risk of fragility fracture

In development [GID-NG10216] Expected publication date: 21 February 2024

Type

NICE guideline

Status

In development
Head injury: assessment and early management

In development [GID-NG10164] Expected publication date: 23 February 2023

Type

NICE guideline

Status

In development
Lower urinary tract symptoms in men: management

In development [GID-NG10300] Expected publication date: TBC

Type

NICE guideline

Status

In development
Sebelipase alfa for treating Wolman disease [ID3995]

In development [GID-HST10047] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]

In development [GID-HST10037] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Alcohol-use disorders: prevention (update)

In development [GID-NG10299] Expected publication date: TBC

Type

NICE guideline

Status

In development
Social, emotional and mental wellbeing in primary and secondary education

In development [GID-NG10125] Expected publication date: 06 July 2022

Type

NICE guideline

Status

In development
Stroke rehabilitation in adults

In development [GID-NG10175] Expected publication date: 18 October 2023

Type

NICE guideline

Status

In development
Exploratory economic modelling of SARS-CoV-2 viral detection point of care tests and serology tests

In development [GID-DG10038] Expected publication date: TBC

Type

Diagnostics guidance

Status

In development
Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223

Awaiting development [GID-HST10019] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Awaiting development
SACT

In development [GID-NG10184] Expected publication date: TBC

Type

NICE guideline

Status

In development
Weight Management: preventing, assessing and managing overweight and obesity (update)

In development [GID-NG10182] Expected publication date: 22 June 2023

Type

NICE guideline

Status

In development
Managing common infections - antimicrobial prescribing guidelines

In development [GID-NG10050] Expected publication date: TBC

Type

NICE guideline

Status

In development
Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]

In development [GID-HST10004] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Urinary tract infection in under 16s: diagnosis and management

In development [GID-NG10259] Expected publication date: 27 July 2022

Type

NICE guideline

Status

In development
Maternal and child nutrition

In development [GID-NG10191] Expected publication date: 22 November 2023

Type

NICE guideline

Status

In development
Obesity: identification and classification of overweight and obesity (update)

In development [GID-NG10284] Expected publication date: 08 September 2022

Type

NICE guideline

Status

In development
Lonafarnib for treating progeria and progeroid laminopathies [ID3867]

Awaiting development [GID-HST10039] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Awaiting development
VTS-270 for treating Niemann-Pick type C1 (ID1267)

Awaiting development [GID-HST10020] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Awaiting development
OTL-101 for treating adenosine deaminase deficiency–severe combined immunodeficiency [ID1152]

Awaiting development [GID-HST10022] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Awaiting development
Epilepsies in adults: diagnosis and management update (Please see Epilepsies in children, young people and adults)

In development [GID-NG10110] Expected publication date: TBC

Type

NICE guideline

Status

In development
Maralixibat for treating type 2 progressive familial intrahepatic cholestasis ID3818

In development [GID-HST10040] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Quantitative faecal immunochemical tests to guide colorectal cancer pathway referral for people with a change in bowel habit or abdominal pain

In development [GID-DG10036] Expected publication date: TBC

Type

Diagnostics guidance

Status

In development
Leriglitazone for treating andrenoleukodystrophy [ID3903]

Awaiting development [GID-HST10049] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Awaiting development
Human alpha1-proteinase inhibitor for treating emphysema ID856

In development [GID-HST10017] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Rehabilitation for chronic neurological disorders including acquired brain injury

In development [GID-NG10181] Expected publication date: 13 December 2023

Type

NICE guideline

Status

In development
Genedrive MT-RNR1 ID System for detecting single nucleotide polymorphism m.1555A G in newborn babies (provisional title)

In development [GID-DG10057] Expected publication date: 13 September 2023

Type

Diagnostics guidance

Status

In development
Clopidogrel genotype testing after ischaemic stroke (provisional title)

In development [GID-DG10054] Expected publication date: 16 August 2023

Type

Diagnostics guidance

Status

In development
Diabetic retinopathy

In development [GID-NG10256] Expected publication date: 03 April 2024

Type

NICE guideline

Status

In development
Transperineal biopsy for diagnosing prostate cancer

In development [GID-DG10043] Expected publication date: 22 June 2022

Type

Diagnostics guidance

Status

In development
Thyroid cancer: assessment and management

In development [GID-NG10150] Expected publication date: 19 December 2022

Type

NICE guideline

Status

In development
MRI-based technologies for assessing non-alcoholic fatty liver disease

In development [GID-DG10045] Expected publication date: 26 October 2022

Type

Diagnostics guidance

Status

In development
MRI-based technologies for assessing non-alcoholic fatty liver disease: diagnostics consultation

We are listening to your views on this Diagnostics guidance. Comments close 14 July 2022.

Type

Diagnostics guidance

Status

In consultation
Cirrhosis in over 16s: assessment and management

In development [GID-NG10355] Expected publication date: 07 February 2024

Type

NICE guideline

Status

In development
Thyroid cancer: assessment and management: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 4 August 2022.

Type

NICE guideline

Status

In consultation
KardiaMobile 6L for measuring QT interval in people having antipsychotic medication

In development [GID-DG10048] Expected publication date: 07 October 2022

Type

Diagnostics guidance

Status

In development
Harmful gambling: identification, assessment and management

In development [GID-NG10210] Expected publication date: 07 February 2024

Type

NICE guideline

Status

In development
Self harm: assessment, management and preventing recurrence

In development [GID-NG10148] Expected publication date: 07 September 2022

Type

NICE guideline

Status

In development
Haemochromatosis

In development [GID-NG10287] Expected publication date: TBC

Type

NICE guideline

Status

In development
Fertility problems: assessment and treatment

In development [GID-NG10263] Expected publication date: TBC

Type

NICE guideline

Status

In development
Otitis media with effusion in under 12s

In development [GID-NG10193] Expected publication date: 28 September 2023

Type

NICE guideline

Status

In development